Advertisement
Original Study - Brief Report| Volume 21, ISSUE 6, P879-883.e1, June 2020

Psychometric Properties of the National Institute of Neurological Disorders and Stroke and Canadian Stroke Network Neuropsychological Battery in an Asian Older Adult Sample

      Abstract

      Objective

      Despite the wide usage of the National Institute of Neurological Disorders and Stroke and Canadian Stroke Network (NINDS-CSN) neuropsychological battery for the detection of vascular cognitive impairment, its reliability and validity have not been established. Therefore, the present study established the psychometric properties of the battery in cognitively normal older adults in a clinical setting in Singapore.

      Design

      Longitudinal study.

      Setting and Participants

      A total of 105 cognitively normal older adults age 50 years and older were assessed in a memory clinic setting.

      Methods

      The 60-minute NINDS-CSN and 5-minute protocol were administered to participants at baseline and 3-month follow-up. Raw scores were transformed into standardized z scores. Test-retest reliability, concurrent validity and construct (convergent and discriminant) validity were reported.

      Results

      Moderate-to-excellent test-retest reliability (r = 0.36–0.87), concurrent validity, and construct validity (r = 0.41–0.83) were found in both protocols over 3 months (all Ps < 0.01). Although the 5-minute protocol showed moderate validity (r = 0.41), the 60-minute protocol had excellent concurrent validity against a locally validated neuropsychological battery (r = 0.83).

      Conclusion and Implications

      The NINDS-CSN is reliable and valid in assessing cognitive function. The 60-minute protocol demonstrates great utility beyond its current usage in vascular cognitive impairment populations to the general older adult population. The 5-minute protocol can be used as a brief cognitive screening tool in primary healthcare and the community, due to its brevity and accuracy. Future research should further examine the generalizability of the NINDS-CSN battery in other dementias and cognitive disorders.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chan Q.L.
        • Shaik M.A.
        • Xu J.
        • et al.
        The combined utility of a brief functional measure and performance-based screening test for case finding of cognitive impairment in primary healthcare.
        J Am Med Dir Assoc. 2016; 17 (372.e9‒372.e11)
        • Eichler T.
        • Thyrian J.R.
        • Hertel J.
        • et al.
        Rates of formal diagnosis of dementia in primary care: The effect of screening.
        Alzheimers Dement (Amst). 2015; 1: 87-93
        • Lang L.
        • Clifford A.
        • Wei L.
        • et al.
        Prevalence and determinants of undetected dementia in the community: A systematic literature review and a meta-analysis.
        BMJ Open. 2017; 7: e011146
        • World Health Organisation
        Dementia. 2019.
        (Available at:) (Accessed June 19, 2019)
        • Borson S.
        • Frank L.
        • Bayley P.J.
        • et al.
        Improving dementia care: the role of screening and detection of cognitive impairment.
        Alzheimers Dement. 2013; 9: 151-159
        • Ministry of Health Singapore
        Recognising dementia. 2019.
        (Available at:) (Accessed July 4, 2019)
        • Hachinski V.
        • Iadecola C.
        • Petersen R.C.
        • et al.
        National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards.
        Stroke. 2006; 37: 2220-2241
        • Strauss E.
        • Sherman E.M.S.
        • Spreen O.
        A compendium neuropsychological tests: administration, norms, and commentary.
        3rd edtition. Oxford University Press, New York2006
        • Stebbins G.T.
        Neuropsychological testing.
        in: Goetz C. Textbook of Clinical Neurology. Third Edition. 2007
        • Chen X.
        • Wong A.
        • Ye R.
        • et al.
        Validation of NINDS-CSN neuropsychological battery for vascular cognitive impairment in Chinese stroke patients.
        BMC Neurol. 2015; 15: 20
        • Han D.Y.
        • Andersen A.J.
        • Jones J.E.
        • et al.
        Neuropsychology in multidisciplinary stroke care: Clinical feasibility of the NINDS-CSN vascular cognitive impairment harmonization standards.
        Int Sch Res Notices. 2014; 2014: 216024
        • Kennedy R.E.
        • Wadley V.G.
        • McClure L.A.
        • et al.
        Performance of the NINDS-CSN 5-minute protocol in a national population-based sample.
        J Int Neuropsychol Soc. 2014; 20: 856-867
        • Lin H.F.
        • Chern C.M.
        • Chen H.M.
        • et al.
        Validation of NINDS-VCI neuropsychology protocols for vascular cognitive impairment in Taiwan.
        PLoS One. 2016; 11: e0156404
        • Wong A.
        • Xiong Y.Y.
        • Wang D.
        • et al.
        The NINDS-Canadian stroke network vascular cognitive impairment neuropsychology protocols in Chinese.
        J Neurol Neurosurg Psychiatry. 2013; 84: 499-504
        • Yu K.H.
        • Cho S.J.
        • Oh M.S.
        • et al.
        Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea.
        Stroke. 2013; 44: 786-788
        • Xu X.
        • Chan Q.L.
        • Hilal S.
        • et al.
        The Diagnostic Utility of the NINDS-CSN Neuropsychological Battery in Memory Clinics.
        Dement Geriatr Cogn Dis Extra. 2016; 6: 276-282
        • Wong A.
        • Nyenhuis D.
        • Black S.E.
        • et al.
        Montreal Cognitive Assessment 5-minute protocol is a brief, valid, reliable, and feasible cognitive screen for telephone administration.
        Stroke. 2015; 46: 1059-1064
        • Dong Y.
        • Sharma V.K.
        • Chan B.P.
        • et al.
        The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke.
        J Neurol Sci. 2010; 299: 15-18
        • Ng T.P.
        • Niti M.
        • Chiam P.C.
        • et al.
        Ethnic and educational differences in cognitive test performance on mini-mental state examination in Asians.
        Am J Geriatr Psychiatry. 2007; 15: 130-139
        • Narasimhalu K.
        • Ang S.
        • De Silva D.A.
        • et al.
        Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort.
        Neurology. 2009; 1: 1866-1872
        • Yeo D.
        • Gabriel C.
        • Chen C.
        • et al.
        Pilot validation of a customized neuropsychological battery in elderly Singaporeans.
        Neurol J South East Asia. 1997; 2: 123
        • Freichs R.J.
        • Tuokko H.A.
        A comparison of methods for measuring cognitive change in older adults.
        Arch Clinl Neuropsychol. 2005; 20: 321-333
        • Lezak M.
        • Howieson D.
        • Loring D.
        Neuropsychological Assessment.
        4th edition. Oxford University Press, New York2004
        • Albert M.S.
        • DeKoksy S.T.
        • Dickson D.
        • et al.
        The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
        Alzheimers Dement. 2011; 7: 270-279
        • Harry A.
        • Crowe S.F.
        Is the Boston Naming Test still fit for purpose?.
        Clin Neuropsychol. 2014; 28: 486-504
        • Brooks B.L.
        • Strauss E.
        • Sherman E.M.S.
        • et al.
        Developments in neuropsychological assessment: Refining psychometric and clinical interpretive methods.
        Can Psychol. 2009; 50: 196-209
        • Bennett-Levy J.
        Determinants of performance on the Rey-Osterrieth Complex Figure Test: An analysis, and a new technique for single-case assessment.
        British Journal of Clin Psychol. 1984; 23: 109-119
        • Chan Q.L.
        • Xu X.
        • Shaik M.A.
        • et al.
        Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare.
        J Alzheimers Dis. 2016; 49: 121-127
        • Lim J.
        • Oh M.S.
        • Lee J.-H.
        • et al.
        Prediction of post-stroke dementia using NINDS-CSN 5-minute neuropsychology protocol in acute stroke.
        Int Psychogeriatr. 2017; 29: 777-784
        • Chen X.
        • Fan X.
        • Zhao L.
        • et al.
        Telephone-based cognitive screening for stroke patients in China.
        Int Psychogeriatr. 2015; 27: 2079-2085